Citations as recorded by:

1. Oestrogens and oestrogen receptors in prostate cancer

SpringerPlus, 2016, 5(1)

DOI: 10.1186/s40064-016-2185-6

Citations as recorded by: Cross Ref PMC Google

2. Oral ethinylestradiol in castration-resistant prostate cancer: A 10-year experience

Int J Urol, 2015, 22(1) p. 98

DOI: 10.1111/iju.12613

Citations as recorded by: Cross Ref

3. Gene Expression Profiling Analysis of Castration-Resistant Prostate Cancer

Med Sci Monit, 2015, 21 p. 205

DOI: 10.12659/MSM.891193

Citations as recorded by: Google

4. Oral ethinylestradiol in castration‐resistant prostate cancer: A 10‐year experience

Year: 2015

Citations as recorded by: Google

5. Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer

PLoS ONE, 2014, 9(5) p. e98037

DOI: 10.1371/journal.pone.0098037

Citations as recorded by: Cross Ref PMC Google

6. Diethylstilboestrol for the treatment of prostate cancer: past, present and future

Scandinavian Journal of Urology, 2014, 48(1) p. 4

DOI: 10.3109/21681805.2013.861508

Citations as recorded by: Cross Ref Google

7. Aberrant Methylation of Protocadherin 17 and its Clinical Significance in Patients with Prostate Cancer after Radical Prostatectomy

Med Sci Monit, 2014, 20 p. 1376

DOI: 10.12659/MSM.891247

Citations as recorded by: Cross Ref PMC Google

8. Promoter Methylation of Protocadherin8 is an Independent Prognostic Factor for Biochemical Recurrence of Early-Stage Prostate Cancer

Med Sci Monit, 2014, 20 p. 2584

DOI: 10.12659/MSM.893083

Citations as recorded by: Cross Ref PMC Google

9. Biology and Clinical Relevance of Estrogen Receptors in Prostate Cancer

Year: 2013

Citations as recorded by: Google